Guided Therapeutics, Inc.
GTHP
$0.29
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.10% | -6.22% | -68.91% | 3.40% | 54.46% |
| Total Depreciation and Amortization | 12.50% | 8.70% | 9.09% | 14.29% | 9.09% |
| Total Amortization of Deferred Charges | 277.78% | 109.38% | -36.36% | -31.25% | -45.45% |
| Total Other Non-Cash Items | 871.43% | -176.92% | 100.00% | -60.95% | -97.48% |
| Change in Net Operating Assets | -35.76% | -94.02% | 61.76% | 483.33% | 1,044.44% |
| Cash from Operations | 21.03% | -231.00% | 1.19% | 0.00% | 51.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 77.50% | -- | -- | -- | -- |
| Total Debt Repaid | 48.92% | -219.57% | -364.44% | 46.10% | -239.02% |
| Issuance of Common Stock | -- | -- | 121.99% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -164.71% | -- | -- | -- | -- |
| Cash from Financing | 443.18% | 226.09% | 168.37% | 354.55% | 207.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.18% | -86.99% | 238.57% | 87.08% | 64.51% |